Paul K Wotton - Net Worth and Insider Trading
Paul K Wotton Net Worth
The estimated net worth of Paul K Wotton is at least $6 Million dollars as of 2024-11-29. Paul K Wotton is the President and CEO of Antares Pharma Inc and owns about 708,734 shares of Antares Pharma Inc (ATRS) stock worth over $4 Million. Paul K Wotton is also the Director of Vericel Corp and owns about 26,802 shares of Vericel Corp (VCEL) stock worth over $2 Million. Details can be seen in Paul K Wotton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul K Wotton has not made any transactions after 2023-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul K Wotton
Paul K Wotton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul K Wotton owns 3 companies in total, including Vericel Corp (VCEL) , Ocata Therapeutics Inc (OCAT) , and Antares Pharma Inc (ATRS) .
Click here to see the complete history of Paul K Wotton’s form 4 insider trades.
Insider Ownership Summary of Paul K Wotton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VCEL | Vericel Corp | 2023-12-14 | director |
| OCAT | Ocata Therapeutics Inc | 2016-02-10 | director & President and CEO |
| ATRS | Antares Pharma Inc | 2014-01-15 | director |
Paul K Wotton Latest Holdings Summary
Paul K Wotton currently owns a total of 2 stocks. Among these stocks, Paul K Wotton owns 708,734 shares of Antares Pharma Inc (ATRS) as of January 15, 2014, with a value of $4 Million and a weighting of 71.9%. Paul K Wotton also owns 26,802 shares of Vericel Corp (VCEL) as of December 14, 2023, with a value of $2 Million and a weighting of 28.1%.
Latest Holdings of Paul K Wotton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATRS | Antares Pharma Inc | 2014-01-15 | 708,734 | 5.59 | 3,961,823 |
| VCEL | Vericel Corp | 2023-12-14 | 26,802 | 57.76 | 1,548,084 |
Holding Weightings of Paul K Wotton
Paul K Wotton Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul K Wotton has made a total of 0 transactions in Antares Pharma Inc (ATRS) over the past 5 years. The most-recent trade in Antares Pharma Inc is the sale of 22,900 shares on January 15, 2014, which brought Paul K Wotton around $116,790.
According to the SEC Form 4 filings, Paul K Wotton has made a total of 2 transactions in Vericel Corp (VCEL) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Vericel Corp is the sale of 5,000 shares on December 14, 2023, which brought Paul K Wotton around $186,550.
Insider Trading History of Paul K Wotton
- 1
Paul K Wotton Trading Performance
GuruFocus tracks the stock performance after each of Paul K Wotton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul K Wotton is 35.28%. GuruFocus also compares Paul K Wotton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul K Wotton within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul K Wotton's insider trading performs compared to the benchmark.
Performance of Paul K Wotton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.94 | | | | | |
| Relative Return to S&P 500(%) | -15.72 | | | | | |
Paul K Wotton Ownership Network
Paul K Wotton Owned Company Details
What does Vericel Corp do?
Who are the key executives at Vericel Corp?
Paul K Wotton is the director of Vericel Corp. Other key executives at Vericel Corp include director & President and CEO Dominick Colangelo , Chief Medical Officer Jonathan Mark Hopper , and SVP & General Counsel Sean C. Flynn .
Vericel Corp (VCEL) Insider Trades Summary
Over the past 18 months, Paul K Wotton made 1 insider transaction in Vericel Corp (VCEL) with a net sale of 5,000. Other recent insider transactions involving Vericel Corp (VCEL) include a net sale of 431,849 shares made by Dominick Colangelo , a net sale of 28,500 shares made by Zerbe Robert L Md , and a net sale of 47,768 shares made by Sean C. Flynn .
In summary, during the past 3 months, insiders sold 152,000 shares of Vericel Corp (VCEL) in total and bought 0 shares, with a net sale of 152,000 shares. During the past 18 months, 607,779 shares of Vericel Corp (VCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 607,779 shares.
Vericel Corp (VCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vericel Corp Insider Transactions
Paul K Wotton Mailing Address
Above is the net worth, insider trading, and ownership report for Paul K Wotton. You might contact Paul K Wotton via mailing address: C/o Antares Pharma, Inc., 707 Eagleview Boulevard, Suite 414, Exton Pa 19341.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
